Torrent Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
106312.48 Cr.
|
P/BV
|
14.17
|
Book Value (Rs.)
|
221.73
|
52 Week High/Low (Rs.)
|
3591/2520
|
FV/ML
|
5/1
|
P/E(X)
|
64.18
|
Bookclosure
|
01/02/2025
|
EPS (Rs.)
|
48.94
|
Div Yield (%)
|
0.89
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
No. of Equity Shares (in Lacs) | 3384.45 | 3384.45 | 1692.23 | 1692.23 | 1692.23 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 |
Total Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 |
| | | | | |
Reserves and Surplus | 6686.92 | 6028.84 | 5868.33 | 5752.55 | 4738.60 |
Total Reserves and Surplus | 6686.92 | 6028.84 | 5868.33 | 5752.55 | 4738.60 |
Total Shareholders Funds | 6856.15 | 6198.07 | 5952.95 | 5837.17 | 4823.22 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 1603.78 | 2496.22 | 2123.22 | 2941.07 | 3275.22 |
Deferred Tax Liabilities [Net] | 656.05 | 401.94 | 193.56 | 0.00 | 0.00 |
Other Long Term Liabilities | 74.66 | 75.26 | 46.28 | 35.17 | 118.80 |
Long Term Provisions | 444.69 | 393.06 | 368.74 | 369.62 | 338.34 |
Total Non-Current Liabilities | 2779.18 | 3366.48 | 2731.80 | 3345.86 | 3732.36 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 2333.64 | 2801.08 | 1894.88 | 1884.39 | 1090.85 |
Trade Payables | 2089.32 | 1678.80 | 1674.44 | 2066.81 | 2048.81 |
Other Current Liabilities | 602.15 | 573.71 | 434.74 | 509.36 | 1895.92 |
Short Term Provisions | 400.14 | 393.71 | 411.03 | 431.06 | 418.58 |
Total Current Liabilities | 5425.25 | 5447.30 | 4415.09 | 4891.62 | 5454.16 |
| | | | | |
Total Capital And Liabilities | 15060.58 | 15011.85 | 13099.84 | 14074.65 | 14009.74 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 3296.97 | 2771.60 | 2702.59 | 2883.34 | 2953.31 |
Intangible Assets | 4503.11 | 5012.35 | 3460.58 | 3840.06 | 4237.72 |
Capital Work-In-Progress | 280.80 | 688.24 | 544.34 | 745.41 | 576.61 |
Intangible Assets Under Development | 79.71 | 77.16 | 85.48 | 143.97 | 135.32 |
Fixed Assets | 8160.59 | 8549.35 | 6792.99 | 7612.78 | 7902.96 |
Goodwill On Consolidation | 338.03 | 337.50 | 259.48 | 341.23 | 342.09 |
Non-Current Investments | 31.80 | 42.70 | 42.33 | 42.09 | 2.09 |
Deferred Tax Assets [Net] | 555.13 | 543.67 | 493.65 | 421.66 | 433.21 |
Long Term Loans And Advances | 2.51 | 2.50 | 1.75 | 2.02 | 2.29 |
Other Non-Current Assets | 361.04 | 206.95 | 214.99 | 131.65 | 346.18 |
Total Non-Current Assets | 9449.10 | 9682.67 | 7805.19 | 8551.43 | 9028.82 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 141.04 | 156.09 | 183.98 | 139.05 | 0.02 |
Inventories | 2279.07 | 2229.64 | 2462.32 | 2681.20 | 2148.22 |
Trade Receivables | 1844.30 | 1943.82 | 1632.48 | 1523.37 | 1649.34 |
Cash And Cash Equivalents | 839.04 | 571.46 | 403.41 | 603.50 | 666.65 |
Short Term Loans And Advances | 3.05 | 1.71 | 2.61 | 3.08 | 3.64 |
OtherCurrentAssets | 504.98 | 426.46 | 609.85 | 573.02 | 513.05 |
Total Current Assets | 5611.48 | 5329.18 | 5294.65 | 5523.22 | 4980.92 |
| | | | | |
Total Assets | 15060.58 | 15011.85 | 13099.84 | 14074.65 | 14009.74 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 575.06 | 619.01 | 505.35 | 324.34 | 374.59 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 162.41 | 162.41 | 77.80 | 77.80 | 77.80 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 31.80 | 42.70 | 42.33 | 42.09 | 2.09 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Unquoted Book Value | 141.04 | 156.06 | 183.98 | 139.05 | 0.00 |